| Bioactivity | Adrixetinib (TFA) is an inhibitor of protein tyrosine kinase with antineoplastic activity[1][2][3]. |
| Name | Adrixetinib TFA |
| Formula | C27H25F6N5O7 |
| Molar Mass | 645.51 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Nam Kiyean, et al. Quinoline derivatives as inhibitors of Axl/Mer RTK and CSF1R and their preparation: World Intellectual Property Organization, WO2019229251. 2019-12-05. [3]. WHO Drug Information-World Health Organization (WHO). |